Fund Holdings — Pivotal bioVenture Partners Investment Advisor LLC

Total Portfolio Value:
$161.34M
Total Bought:
$24.14M
Total Sold:
$756.6K
Net Transaction:
+$23.38M
Notable People:
Robert Lorne Hopfner, Peter Tuxen Bisgaard, Pivotal Bioventure Partners, Pivotal Partners Ltd
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Oculis Holding AG(OCS)2,300,7742,300,7740$43.78M$44.66M27.68%+$874.3K
Vaxcyte, Inc.(PCVX)710,7341,305,125+594,391$26.84M$42.43M26.30%+$15.59M
Arcutis Biotherapeutics, Inc.(ARQT)2,120,5082,120,5080$33.16M$29.73M18.43%-$3.44M
Inozyme Pharma Inc4,494,8514,494,8510$4.09M$17.98M11.14%+$13.89M
Zenas BioPharma, Inc.(ZBIO)736,645779,045+42,400$5.82M$7.55M4.68%+$1.73M
Trevi Therapeutics, Inc.(TRVI)01,146,110+1,146,110$0$6.27M3.89%+$6.27M
Vigil Neuroscience Inc560,595560,5950$997.9K$4.46M2.76%+$3.46M
Recursion Pharmaceuticals, Inc.CL A(RXRX)595,518595,5180$3.15M$3.01M1.87%-$137.0K
BioAge Labs, Inc.(BIOA)653,374653,3740$2.46M$2.70M1.67%+$241.7K
Io Biotech Inc864,197864,1970$942.0K$1.20M0.74%+$259.3K
Rallybio Corporation(RLYB)2,404,6442,404,6440$1.56M$812.8K0.50%-$750.2K
Bolt Biotherapeutics Inc094,573+94,573$0$545.7K0.34%+$545.7K
Bolt Biotherapeutics Inc1,891,4670-1,891,467$756.6K$0—-$756.6K
Page 1 of 1
Pivotal bioVenture Partners Investment Advisor LLC — 13F Holdings — Q2 2025 | TickerTrail